Hematology & Oncology
The Division of Hematology & Oncology is the driving force behind the Cardinal Bernardin Cancer Center, the second largest cancer center in Illinois.
Faculty have expertise in several clinical areas but are very active in Loyola University Medical Center's Graduate Medical Education programs. They teach and/or lead various courses and lectures for the hematology/oncology fellows in our ACGME Accredited Hematology/Oncology Fellowship Program, Loyola University Medical Center residents, and Stritch School of Medicine medical students. The faculty also participates at annual board reviews, grand rounds, and a variety of Continuing Medical Education (CME) programs.
Fellowship Program
The fellowship program of the Division of Hematology & Oncology is a three-year training program, culminating in dual ABIM board eligibility. Our aim is to produce superior subspecialists who are prepared for careers in academic medicine or community practice.
The Medical Oncology training emphasizes methods of diagnosis; staging, management and treatment of solid tumors through rotations on the inpatient oncology consult service, outpatient subspecialty clinics, and infusion center experiences. The Hematology training focuses on coagulation, hematologic malignancies, anemias, hemoglobinopathies, and disorders of leukocytes and platelets. This is achieved with rotations on the inpatient BMT-ICU service and hematology consult service. To round out the fellowship, elective rotations are available in Radiation Oncology, Gynecologic Oncology, Hematopathology, Blood Bank, Palliative Care, Community Practice, and our High Dose Therapy Unit for post-transplant or post-induction care of hematologic malignancies.
Hematology/Oncology Fellows are expected to be involved in research endeavors relevant to this subspecialty. Opportunities in basic science research, translational research, and clinical research, are plentiful. Additional areas of academic activities expected of fellows include quality improvement projects and medical education of medicine residents and medical students.
Program Director: Nina Undevia Yedavalli, MD, MPH
Associate Program Director: Kirk Cahill, MD
Research
The Division of Hematology & Oncology faculty are actively involved in research on many levels, from basic science to translational to clinical research. We have nationally funded physician scientists and basic scientists with whom we collaborate. Loyola has been a long time member institution of the Southwest Oncology Group (SWOG), a national cooperative group committed to practice changing clinical research in hematology/oncology. All cooperative group trials are available through the National Clinical Trials Network (NCTN). Investigator initiated trials and pharmaceutical-sponsored clinical trials are integral components of our research portfolio as well.
Faculty
Joseph Clark, MD
Professor of Medicine
Eugene Ahn, MD
Assistant Professor
Andrea Amico, MD
Assistant Professor
Kathy S. Albain, MD
Professor of Medicine
Nirav Antao, DO
Assistant Professor
Kevin Barton, MD
Professor of Medicine
Leela Bhupalam, MD
Assistant Professor
Kirk Cahill, MD
Assistant Professor
Patrick Hagen, MD
Associate Professor of Medicine
May Hashimi, MD
Assistant Professor of Medicine
Kathleen Kennedy, MD
Assistant Professor
Jorgena Kosti- Schwartz, DO
Assistant Professor
Imran Puthawala, MD
Assistant Professor
Nan Sethakorn, MD
Assistant Professor of Medicine
Stephanie Tsai, MD
Assistant Professor
Jennifer Weiss, MD
Assistant Professor
Nina Yedavalli, MD
Assistant Professor of Medicine
The Division of Hematology & Oncology is the driving force behind the Cardinal Bernardin Cancer Center, the second largest cancer center in Illinois.
Faculty have expertise in several clinical areas but are very active in Loyola University Medical Center's Graduate Medical Education programs. They teach and/or lead various courses and lectures for the hematology/oncology fellows in our ACGME Accredited Hematology/Oncology Fellowship Program, Loyola University Medical Center residents, and Stritch School of Medicine medical students. The faculty also participates at annual board reviews, grand rounds, and a variety of Continuing Medical Education (CME) programs.
Fellowship Program
The fellowship program of the Division of Hematology & Oncology is a three-year training program, culminating in dual ABIM board eligibility. Our aim is to produce superior subspecialists who are prepared for careers in academic medicine or community practice.
The Medical Oncology training emphasizes methods of diagnosis; staging, management and treatment of solid tumors through rotations on the inpatient oncology consult service, outpatient subspecialty clinics, and infusion center experiences. The Hematology training focuses on coagulation, hematologic malignancies, anemias, hemoglobinopathies, and disorders of leukocytes and platelets. This is achieved with rotations on the inpatient BMT-ICU service and hematology consult service. To round out the fellowship, elective rotations are available in Radiation Oncology, Gynecologic Oncology, Hematopathology, Blood Bank, Palliative Care, Community Practice, and our High Dose Therapy Unit for post-transplant or post-induction care of hematologic malignancies.
Hematology/Oncology Fellows are expected to be involved in research endeavors relevant to this subspecialty. Opportunities in basic science research, translational research, and clinical research, are plentiful. Additional areas of academic activities expected of fellows include quality improvement projects and medical education of medicine residents and medical students.
Program Director: Nina Undevia Yedavalli, MD, MPH
Associate Program Director: Kirk Cahill, MD
Research
The Division of Hematology & Oncology faculty are actively involved in research on many levels, from basic science to translational to clinical research. We have nationally funded physician scientists and basic scientists with whom we collaborate. Loyola has been a long time member institution of the Southwest Oncology Group (SWOG), a national cooperative group committed to practice changing clinical research in hematology/oncology. All cooperative group trials are available through the National Clinical Trials Network (NCTN). Investigator initiated trials and pharmaceutical-sponsored clinical trials are integral components of our research portfolio as well.